Oral Oncology
Volume 37, Issue 7 , Pages 579-585, October 2001

Alteration of pRb expression in the development of rat tongue carcinoma induced by 4-nitroquinoline 1-oxide

  • Shinya Niwa

      Affiliations

    • Graduate School of Dentistry, First Department of Oral and Maxillofacial Surgery, Osaka Dental University, 8-1 Kuzuhahanazono-cho, Hirakata-shi Osaka 573-1121, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81-72-864-3080; fax: +81-72-864-3180
  • ,
  • Shigeru Ueno

      Affiliations

    • First Department of Oral and Maxillofacial Surgery, Osaka Dental University, Osaka Dental University, 8-1 Kuzuhahanazono-cho, Hirakata-shi Osaka 573-1121, Japan
  • ,
  • Rikiya Shirasu

      Affiliations

    • First Department of Oral and Maxillofacial Surgery, Osaka Dental University, Osaka Dental University, 8-1 Kuzuhahanazono-cho, Hirakata-shi Osaka 573-1121, Japan

Received 5 November 2000; accepted 15 November 2000.

Abstract 

We investigated the immunohistochemical expression of Rb protein (pRb), which plays an important role in the regulation of the cell cycle, in rat tongue carcinoma induced by 4-nitroquinoline 1-oxide. In addition, we made an immunohistochemical investigation of cyclin D1 and cdk4, which are involved in the Rb pathway. The labeling index of pRb expression in cases with carcinoma was significantly decreased compared with that in cases with a premalignant lesion (P<0.01), while the labeling index of cyclin D1 and cdk4 increased gradually during the course of carcinogenesis. We analyzed the phosphorylation of pRb by immunoblotting using G3-245 monoclonal antibody, which recognizes both the phosphorylated and unphosphorylated forms of pRb. Although expression of the phosphorylated pRb band was notably increased in dysplastic membrane compared with the control membrane, it almost disappeared in cases with carcinoma. Unphosphorylated pRb bands were also expressed in control membrane and dysplastic membrane but not in cases with carcinoma. In conclusion, a decrease of pRb and an increase of cdk4 and cyclin D1 were shown to occur during the premalignant stage. The decrease of pRb in quantity and the increase of its phosphorylation may prevent G1 arrest and consequently accelerate proliferation of the chemically injured cells contributing to the initiation of carcinogenesis.

Keywords:  Rb pathway, Product of retinoblastoma gene (pRb), 4-nitroquinoline 1-oxide (4NQO), Squamous cell carcinoma

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1368-8375(00)00141-X

Oral Oncology
Volume 37, Issue 7 , Pages 579-585, October 2001